Your browser doesn't support javascript.
loading
miRNAs associated with prostate cancer risk and progression.
Luu, Hung N; Lin, Hui-Yi; Sørensen, Karina Dalsgaard; Ogunwobi, Olorunseun O; Kumar, Nagi; Chornokur, Ganna; Phelan, Catherine; Jones, Dominique; Kidd, LaCreis; Batra, Jyotsna; Yamoah, Kosj; Berglund, Anders; Rounbehler, Robert J; Yang, Mihi; Lee, Sang Haak; Kang, Nahyeon; Kim, Seung Joon; Park, Jong Y; Di Pietro, Giuliano.
Afiliação
  • Luu HN; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
  • Lin HY; Department of Epidemiology and Biostatistics, College of Public Health, University of South Florida, Tampa, FL, USA.
  • Sørensen KD; Biostatistics Program, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA, 70112, USA.
  • Ogunwobi OO; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
  • Kumar N; Department of Biological Sciences, Hunter College of The City University of New York, New York, NY, 10065, USA.
  • Chornokur G; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.
  • Phelan C; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.
  • Jones D; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.
  • Kidd L; Department of Pharmacology and Toxicology, James Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY, 40202, USA.
  • Batra J; Department of Pharmacology and Toxicology, James Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY, 40202, USA.
  • Yamoah K; Australian Prostate Cancer Research Centre-QLD, Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Translational Research Institute, Queensland University of Technology, Brisbane, Australia.
  • Berglund A; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.
  • Rounbehler RJ; Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.
  • Yang M; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.
  • Lee SH; Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.
  • Kang N; Research Center for Cell Fate Control, College of Pharmacy, Sookmyoung Women's University, Seoul, Republic of Korea.
  • Kim SJ; Department of Internal Medicine, The Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Park JY; Department of Internal Medicine, The Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Di Pietro G; Department of Internal Medicine, The Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
BMC Urol ; 17(1): 18, 2017 Mar 20.
Article em En | MEDLINE | ID: mdl-28320379
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Progressão da Doença / MicroRNAs Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Progressão da Doença / MicroRNAs Idioma: En Ano de publicação: 2017 Tipo de documento: Article